Propeller Health has announced it will begin distributing in Japan, via a collaboration with Novartis to connect the Pro...
KT Corp., South Korea's largest telecommunications company, is developing a COVID-19 infection risk assessment...
The annual medical forum held by the Asia Pacific Medical Technology Association (APACMed) brings more than 1,000 delega...
Allscripts, a global leader in healthcare IT, cultivates a community-oriented approach to healthcare technology software...
Japan headquartered PHC Holdings Corporation and Ascensia Diabetes Care, a PHC Group company, have announced a strategic...
COVID-19 has exposed the inadequacies in the healthcare industry which is now evolving through vigorous transformation. ...
The ongoing COVID-19 pandemic plaguing countries worldwide has created unprecedented change for the global economy, espe...
Medical imaging professionals such as radiologists, information technology specialists, and medical physicists routinely...
People suffering from glaucoma got bad news and good news from a clinical study published in the jou...
Taiwan based Heroic-Faith which uses deep learning and other forms of AI to develop algorithms that assist in the identi...
Australian government is investing $18.8 million to supercharge the discovery of better treatments for cancer, epilepsy,...
IQVIA™ has announced it is joining forces with US based JDRF, the leading global organization funding type 1 diabe...
Two researchers from the National University of Singapore (NUS) who are members of the Intel Neuromorphic Research ...
Japan based Fujitsu Connected Technologies Limited (FCNT), a national longevity medical research Institute at Obu City, ...
As economies gradually reopen in many cities across Asia and businesses find ways to ease back into what many are callin...
SingHealth and the Agency for Science, Technology and Research (A*STAR), with support from the Integrated Health Informa...
Japanese firm Santen Pharmaceutical Co., Ltd. and US based Orbis International have announced a partnership to develop a...
Treatment effectiveness, health care costs and quality of life outcomes for the two to four percent of Australians with ...
